BioPharmSignal logoBioPharmSignal

Biotech News

MATERIALISE AANDELENINKOOPPROGRAMMA

Materialise (MTLS)MaterialiseCompany update

Leuven – 14 september 2026 – 22h00 CET Gereglementeerde informatie 1 Materialise reports on the progress of its share buy-back program announced on 30 October 2025. 14 september 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“Materialise”) (“de

Related news

MTLSMaterialise2026-09-14 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-08-27 17:33 EST

Materialise rapporteert resultaten over het tweede kwartaal en het eerste halfjaar van 2026

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-09-14 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-09-14 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-09-08 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-09-08 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-08-29 02:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

Stock data

Close
7.71 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States